Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886

Biochemical Journal

Volumn 372, Issue 1, 2003, Pages 203-210

  Tong, Zhimin ^a   Wu, Xuli ^a   Kehrer, James P ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

5 lipoxygenase (LOX); Apoptosis; bcl 2; Lipocalin; Peroxisome proliferator activated receptor (PPAR)

Indexed keywords

CELLS; PROTEINS; RNA;

APOPTOTIC MECHANISM;

BIOCHEMISTRY;

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CIGLITAZONE; LIPOCALIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; DNA DEGRADATION; ENZYME ACTIVITY; GENE INDUCTION; IMAGE ENHANCEMENT; LIPID PEROXIDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN SYNTHESIS INHIBITION; RECEPTOR UPREGULATION; STEM CELL;

ACUTE-PHASE PROTEINS; ANIMALS; APOPTOSIS; CARCINOGENS; CASPASE 3; CASPASES; GENE EXPRESSION REGULATION; INDOLES; LIPOXYGENASE INHIBITORS; MICE; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRIMIDINES; THIAZOLES; THIAZOLIDINEDIONES;

ANIMALIA; MURINAE;

EID: 0037616349     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20021696     Document Type: Article

References (44)

1. Ferreira, C. G., Epping, M., Kruyt, F. A. and Giaccone, G. (2002) Apoptosis: target of cancer therapy. Clin. Cancer Res. 8, 2024-2034
2. Bellamy, C. O., Malcomson, R. D., Harrison, D. J. and Wyllie, A. H. (1995) Cell death in health and disease: the biology and regulation of apoptosis. Semin. Cancer Biol. 6, 3-16
3. Jacobson, M. D., Weil, M. and Raff, M. C. (1997) Programmed cell death in animal development. Cell (Cambridge, Mass.) 88, 347-354
4. Thompson, C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science (Washington, D.C.) 267, 1456-1462
5. Mohr, S., Zech, B., Lapetina, E. G. and Brune, B. (1997) Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide. Biochem. Biophys. Res. Commun. 238, 387-391
6. Tang, D. G., La, E., Kern, J. and Kehrer, J. P. (2002) Fatty acid oxidation and signaling in apoptosis. Biol. Chem. 383, 425-442
7. Tang, D. G., Chen, Y. Q. and Honn, K. V. (1996) Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc. Natl. Acad. Sci. U.S.A. 93, 5241-5246
8. Brash, A. R. (1999) Lipoxygenases: occurrence, functions, catalysis and acquisition of substrate. J. Biol. Chem. 274, 23579-23682
9. Kuhn, H. and Thiele, B. J. (1999) The diversity of the lipoxygenase family. Many sequence data but little information on biological significance. FEBS Lett. 449, 7-11
10. Harris, R. R., Carter, G. W., Bell, R. L., Moore, J. L. and Brooks, D. W. (1995) Clinical activity of leukotriene inhibitors. Int. J. Immunopharmacol. 17, 147-156
11. Rouzer, C. A., Ford-Hutchinson, A. W., Morton, H. E. and Gillard, J. W. (1990) MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. J. Biol. Chem. 265, 1436-1442
12. Avis, I. M., Jett, M., Boyle, T., Vos, M. D., Moody, T., Treston, A. M., Martinez, A. and Mulshine, J. L. (1996) Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J. Clin. Invest. 97, 806-813
13. Datta, K., Biswal, S. S. and Kehrer, J. P. (1999) The 5-lipoxygenase-activating protein (FLAP) inhibitor, MK886, induces apoptosis independently of FLAP. Biochem. J. 340, 371-375
14. Avis, I., Hong, S. H., Martinez, A., Moody, T., Choi, Y. H., Trepel, J., Das, R., Jett, M. and Mulshine, J. L. (2001) Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J. 15, 2007-2009
15. L expression in murine pro-B lymphocytic FL5.12 cells. J. Biol. Chem. 273, 28163-28169
16. Gugliucci, A., Ranzato, L., Scorrano, L., Colonna, R., Petronilli, V., Cusan, C., Prato, M., Mancini, M., Pagano, F. and Bernardi, P. (2002) Mitochondria are direct targets of the lipoxygenase inhibitor MK886. A strategy for cell killing by combined treatment with MK886 and cycloxygenase inhibitors. J. Biol. Chem. 277, 31789-31795
17. Bratt, T. (2000) Lipocalins and cancer. Biochim. Biophys. Acta 1462, 318-326
18. Hraba-Renevey, S., Turler, H., Kress, M., Salomon, C. and Weil, R. (1989) SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. Oncogene 4, 601-608
19. Meheus, L. A., Fransen, L. M., Raymackers, J. G., Blockx, H. A., Van Beeumen, J. J., Van Bun, S. M. and Van de Voorde, A. (1993) Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages. J. Immunol. 151, 1535-1547
20. Davis, T. R., Tabatabai, L., Bruns, K., Hamilton, R. T. and Nilsen-Hamilton, M. (1991) Basic fibroblast growth factor induces 3T3 fibroblasts to synthesize and secrete a cyclophilin-like protein and β2-microglobugn. Biochim. Biophys. Acta 1095, 145-152
21. Liu, Q. and Nilsen-Hamilton, M. (1995) Identification of a new acute phase protein. J. Biol. Chem. 270, 22565-22570
22. Garay-Rojas, E., Harper, M., Hraba-Renevey, S. and Kress, M. (1996) An apparent autocrine mechanism amplifies the dexamethasone- and retinoic acid-induced expression of mouse lipocalin-encoding gene 24p3. Gene 170, 173-180
23. Ryon, J. Bendickson, L. and Nilsen-Hamilton, M. (2002) High expression in involuting reproductive tissues of uterocalin/24p3, a lipocalin and acute phase protein. Biochem. J. 367, 271-277
24. Chu, S. T., Lin, H. J., Huang, H. L. and Chen, Y. H. (1998) The hydrophobic pocket of 24p3 protein from mouse uterine luminal fluid: fatty acid and retinol binding activity and predicted structural similarity to lipocalins. J. Pept. Res. 52, 390-397
25. Yang, J., Goetz, D., Li, J.-Y., Wang, W., Mori, K., Setlik, D., Du, T., Erdjument-Bromage, H., Tempst, P., Strong, R. and Barasch, J. (2002) An iron delivery pathway mediated by lipocalin. Mol. Cell 10, 1045-1056
26. Devireddy, L. R., Teodoro, J. G., Richard, F. A. and Green, M. R. (2001) Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science (Washington, D.C.) 293, 829-834
27. Kehrer, J. P., Biswal, S. S., La, E., Thuillier, P., Datta, K., Fischer, S. M. and Vanden Heuvel, J. P. (2001) Inhibition of peroxisome-proliferator-activated receptor (PPAR)α by MK886. Biochem. J. 356, 899-906
28. L can differentially block chemotherapy-induced cell death. Blood 90, 1208-1216
29. Wu, X., Biswal, S. and Kehrer, J. P. (2003) Roles of 5-lipoxygenase activating protein in cell proliferation and apoptosis. Cell Biol. Toxicol., in the press
30. Clark-Lewis, I., Thomas, W. R. and Schrader, J. W. (1985) Characterization of hemopoietic growth factors from T cells and the myelomonocytic leukemia WEHI-3B. Exp. Hematol. 13, 304-311
31. La, E., Kern, J. C., Atarod, E. B. and Kehrer, J. P. (2003) Fatty acid release and oxidation in lipoxygenase inhibitor-induced apoptosis. Toxicol. Lett. 138, 193-203
32. Vanden Heuvel, J. P. (1999) Peroxisome proliferator-activated receptors: a critical link among fatty acids, gene expression and carcinogenesis. J. Nutr. 129, 575S-580S
33. Thuillier, P., Brash, A. R., Kehrer, J. P., Stimmel, J. B., Leesnitzer, L. M., Yang, P., Newman, R. A. and Fischer, S. M. (2002) Inhibition of peroxisome proliferator-activated receptor (PPAR)-mediated keratinocyte differentiation by lipoxygenase inhibitors. Biochem. J. 366, 901-910
34. Wang, Y. L., Frauwirth, K. A., Rangwala, S. M., Lazar, M. A. and Thompson, C. B. (2002) Thiazolidinedione activation of peroxisome proliferators-activated receptor γ can enhance mitochondrial potential and promote cell survival. J. Biol. Chem. 277, 31781-31788
35. Haraguchi, K., Shimura, H. and Onaya, T. (2001) Activation of peroxisome proliferators-activated receptor-γ inhibits apoptosis induced by serum deprivation in LLC-PK1 cells. Exp. Nephrol. 10, 393-401
36. Antonsson, B. (2001) Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim the mitochondrion. Cell Tissue Res. 306, 347-361.
37. Mak, T. W. and Yeh, W. C. (2002) Signaling for survival and apoptosis in the immune system. Arthritis Res. 4 (Suppl 3), S243-S252
38. Lee, Y. C., Lin, S. D., Yu, H. M., Chen, S. T. and Chu, S. T. (2001) Phosphorylation of the 24p3 protein secreted from mouse uterus in vitro and in vivo. J. Protein Chem. 20, 563-569
39. Ghosh, J. and Myers, C. E. (1997) Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem. Biophys. Res. Commun. 235, 418-423
40. Ghosh, J. and Myers, C. E. (1998) Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc. Natl. Acad. Sci. U.S.A. 95, 13182-13187
41. Roberts, R. A., James, N. H., Hasmall, S. C., Holden, P. R., Lambe, K., Macdonald, N., West, D., Woodyatt, N. J. and Whitcome, D. (2000) Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPARα. Toxicol. Lett. 112-113, 49-57
42. Hihi, A. K., Michalik, L. and Wahli, W. (2002) PPARs: transcriptional effectors of fatty acids and their derivatives. Cell Mol. Life Sci. 59, 790-798
43. Simonin, M. A., Bordji, K., Boyault, S., Bianchi, A, Gouze, E., Becuwe, P., Dauca, M., Netter, P. and Terlain, B. (2002) PPAR-γ ligands modulate effects of LPS in stimulated rat synovial fibroblasts. Am. J. Physiol Cell. Physiol. 282, C125-C133
44. Jones, D. C., Ding, X. and Daynes, R. A. (2002) Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARα) is expressed in resting murine lymphocytes. The PPARα in T and B lymphocytes is both transactivation and transrepression competent. J. Biol. Chem. 277, 6838-6845